Speaker: Jens Lohr, MD, PhD – Dana-Farber Cancer Institute
Speaker: Mattia D'Agostino, MD – University of Turin
Career Development
Speaker: Jens Lohr, MD, PhD – Dana-Farber Cancer Institute
### @@@ Mattia D'Agostino, MD – University of Turin ### 1949896###Speaker###Assistant professor###University of Turin###Speaker: Mattia D'Agostino, MD – University of Turin
###Speaker: Marta Sonia González, MD (she/her/hers) – H CLINICO UNIVERSITARIO SANTIAGO DE COMPOSTELA
Speaker: Claudio Cerchione, MD, PhD (he/him/his) – Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy
Meet the Professor
Speaker: Marta Sonia González, MD (she/her/hers) – H CLINICO UNIVERSITARIO SANTIAGO DE COMPOSTELA
### she/her/hers @@@ Claudio Cerchione, MD, PhD (he/him/his) – Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy ### 1661147###Speaker###Clinician###Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy###Speaker: Claudio Cerchione, MD, PhD (he/him/his) – Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy
### he/him/hisSpeaker: Angela Dispenzieri, MD – Mayo Clinic Rochester
Speaker: Frits van Rhee, MD PHD (he/him/his) – Myeloma Center, University of Arkansas of Medicine
Meet the Professor
Speaker: Angela Dispenzieri, MD – Mayo Clinic Rochester
### @@@ Frits van Rhee, MD PHD (he/him/his) – Myeloma Center, University of Arkansas of Medicine ### 1954268###Speaker###Professor of Medicine###Myeloma Center, University of Arkansas of Medicine###Speaker: Frits van Rhee, MD PHD (he/him/his) – Myeloma Center, University of Arkansas of Medicine
### he/him/hisSpeaker: Dave Murray, MD PhD – Mayo Clinic
Speaker: Joan Bladé, MD PhD – Amyloidosis and Myeloma Unit. Hospital Clínic de Barcelona. IDIBAPS. University of Barcelona. Barcelona, Spain
Meet the Professor
Speaker: Dave Murray, MD PhD – Mayo Clinic
### @@@ Joan Bladé, MD PhD – Amyloidosis and Myeloma Unit. Hospital Clínic de Barcelona. IDIBAPS. University of Barcelona. Barcelona, Spain ### 1441772###Speaker###Hematologist###Amyloidosis and Myeloma Unit. Hospital Clínic de Barcelona. IDIBAPS. University of Barcelona. Barcelona, Spain###Speaker: Joan Bladé, MD PhD – Amyloidosis and Myeloma Unit. Hospital Clínic de Barcelona. IDIBAPS. University of Barcelona. Barcelona, Spain
###Speaker: Jorge J. Castillo, MD (he/him/his) – Dana-Farber Cancer Institute
Speaker: Andrew R. Branagan, MD, PhD – Massachusetts General Hospital
Meet the Professor
Speaker: Jorge J. Castillo, MD (he/him/his) – Dana-Farber Cancer Institute
### he/him/his @@@ Andrew R. Branagan, MD, PhD – Massachusetts General Hospital ### 1442194###Speaker###Attending Physician###Massachusetts General Hospital###Speaker: Andrew R. Branagan, MD, PhD – Massachusetts General Hospital
###Speaker: Meral Beksac, MD (she/her/hers) – Ankara University
Speaker: Natalie Callander, MD – University of Wisconsin
Meet the Professor
Speaker: Meral Beksac, MD (she/her/hers) – Ankara University
### she/her/hers @@@ Natalie Callander, MD – University of Wisconsin ### 1949893###Speaker###Director, Myeloma Clinical Program###University of Wisconsin###Speaker: Natalie Callander, MD – University of Wisconsin
###Speaker: Carlos Fernandez de Larrea, MD, PhD – Hospital Clínic de Barcelona
Speaker: Andrzej J. Jakubowiak, MD, PhD – University of Chicago, Chicago, IL, USA
Meet the Professor
Speaker: Carlos Fernandez de Larrea, MD, PhD – Hospital Clínic de Barcelona
### @@@ Andrzej J. Jakubowiak, MD, PhD – University of Chicago, Chicago, IL, USA ### 1409087###Speaker###Professor of Medicine; Director, Myeloma Program###University of Chicago, Chicago, IL, USA###Speaker: Andrzej J. Jakubowiak, MD, PhD – University of Chicago, Chicago, IL, USA
###Speaker: Karthik Ramasamy, MBBS FRCP FRCPath PhD – University of Oxford and Oxford University Hospitals NHS FT
Speaker: Dorotea Fantl, MD – Hospital Italiano de Buenos Aires, Argentina.
Meet the Professor
Speaker: Karthik Ramasamy, MBBS FRCP FRCPath PhD – University of Oxford and Oxford University Hospitals NHS FT
### @@@ Dorotea Fantl, MD – Hospital Italiano de Buenos Aires, Argentina. ### 1409082###Speaker###Consultant Physician in the Hematology Department of the Hospital Italiano de Buenos Aires ###Hospital Italiano de Buenos Aires, Argentina.###Speaker: Dorotea Fantl, MD – Hospital Italiano de Buenos Aires, Argentina.
###Co-Chair: MELETIOS DIMOPOULOS, MD (he/him/his) – Department of Clinical Therapeutics/Medical School/National and Kapodistrian University of Athens
Co-Chair: Efstathios Kastritis, MD, PhD (he/him/his) – National and Kapodistrian University of Athens
General Session
Co-Chair: MELETIOS DIMOPOULOS, MD (he/him/his) – Department of Clinical Therapeutics/Medical School/National and Kapodistrian University of Athens
Co-Chair: Efstathios Kastritis, MD, PhD (he/him/his) – National and Kapodistrian University of Athens
General Session
Co-Chair: MELETIOS DIMOPOULOS, MD (he/him/his) – Department of Clinical Therapeutics/Medical School/National and Kapodistrian University of Athens
### he/him/his @@@ Efstathios Kastritis, MD, PhD (he/him/his) – National and Kapodistrian University of Athens ### 1949897###Co-Chair###Professor of Medicine ###National and Kapodistrian University of Athens ###Co-Chair: Efstathios Kastritis, MD, PhD (he/him/his) – National and Kapodistrian University of Athens
### he/him/hisSpeaker: Steven Treon, MD, PhD, FACP, FRCP (he/him/his) – Dana Farber Cancer Institute
General Session
Speaker: Steven Treon, MD, PhD, FACP, FRCP (he/him/his) – Dana Farber Cancer Institute
### he/him/hisSpeaker: Vaishali Sanchorawala, MD (she/her/hers) – Boston University Chobanian & Avedisian School of Medicine
General Session
Speaker: Vaishali Sanchorawala, MD (she/her/hers) – Boston University Chobanian & Avedisian School of Medicine
### she/her/hersChair: Joseph Mikhael, MD – Translational Genomics Research Institute (TGen), City of Hope Cancer Center
Industry Symposium
Chair: Joseph Mikhael, MD – Translational Genomics Research Institute (TGen), City of Hope Cancer Center
Industry Symposium
Chair: Joseph Mikhael, MD – Translational Genomics Research Institute (TGen), City of Hope Cancer Center
###Speaker: Joseph Mikhael, MD – Translational Genomics Research Institute (TGen), City of Hope Cancer Center
Industry Symposium
Speaker: Joseph Mikhael, MD – Translational Genomics Research Institute (TGen), City of Hope Cancer Center
###Speaker: Xavier P. Leleu, MD, PhD (he/him/his) – Hospital La Mileterie, Poitiers, France
Industry Symposium
Speaker: Xavier P. Leleu, MD, PhD (he/him/his) – Hospital La Mileterie, Poitiers, France
### he/him/hisSpeaker: Fredrik Schjesvold, MD, PhD – Oslo Myeloma Center, Department of Hematology, Oslo University Hospital and KG Jebsen Center for B Cell Malignancies, University of Oslo
Industry Symposium
Speaker: Fredrik Schjesvold, MD, PhD – Oslo Myeloma Center, Department of Hematology, Oslo University Hospital and KG Jebsen Center for B Cell Malignancies, University of Oslo
###Speaker: Elizabeth O'Donnell, MD – Massachusetts General Hospital
Industry Symposium
Speaker: Elizabeth O'Donnell, MD – Massachusetts General Hospital
###Chair: Shaji K. Kumar, MD – Mayo Clinic, Rochester, MN, US
Co-Chair: Francesca Gay, MD – Division of Hematology 1, Clinical trial unit AOU città della salute e della scienza, University of Torino
General Session
Chair: Shaji K. Kumar, MD – Mayo Clinic, Rochester, MN, US
Co-Chair: Francesca Gay, MD – Division of Hematology 1, Clinical trial unit AOU città della salute e della scienza, University of Torino
General Session
Chair: Shaji K. Kumar, MD – Mayo Clinic, Rochester, MN, US
### @@@ Francesca Gay, MD – Division of Hematology 1, Clinical trial unit AOU città della salute e della scienza, University of Torino ### 1441897###Co-Chair###Professor / Hematologist###Division of Hematology 1, Clinical trial unit AOU città della salute e della scienza, University of Torino###Co-Chair: Francesca Gay, MD – Division of Hematology 1, Clinical trial unit AOU città della salute e della scienza, University of Torino
###Speaker: Martin F. Kaiser, MD, FRCP, FRCPath – The Institute of Cancer Research; Royal Marsden Hospital
General Session
Speaker: Martin F. Kaiser, MD, FRCP, FRCPath – The Institute of Cancer Research; Royal Marsden Hospital
###Speaker: Moritz Binder, MD MPH (he/him/his) – Mayo Clinic
General Session
Speaker: Moritz Binder, MD MPH (he/him/his) – Mayo Clinic
### he/him/hisSpeaker: Laura Rosinol, MD, PhD (she/her/hers) – Hospital Clínic de Barcelona, IDIBAPS, Barcelona, Spain
General Session
Speaker: Laura Rosinol, MD, PhD (she/her/hers) – Hospital Clínic de Barcelona, IDIBAPS, Barcelona, Spain
### she/her/hersSpeaker: Salomon Manier, MD, PhD – Centre Hospitalier Universitaire de Lille, Université de Lille, Lille, France
General Session
Speaker: Salomon Manier, MD, PhD – Centre Hospitalier Universitaire de Lille, Université de Lille, Lille, France
###Speaker: Ioannis V Kostopoulos, n/a – Section of Animal and Human Physiology, Department of Biology, School of Sciences, National and Kapodistrian University of Athens, Athens, Greece
General Session
Speaker: Ioannis V Kostopoulos, n/a – Section of Animal and Human Physiology, Department of Biology, School of Sciences, National and Kapodistrian University of Athens, Athens, Greece
###Speaker: Clark DuMontier, MD, MPH (he/him/his) – VA Boston Healthcare System and Brigham and Women's Hospital/Harvard Medical School
General Session
Speaker: Clark DuMontier, MD, MPH (he/him/his) – VA Boston Healthcare System and Brigham and Women's Hospital/Harvard Medical School
### he/him/hisSpeaker: Hira Mian, MD, MSc, FRCPC – McMaster University, Hamilton, Ontario, Canada
General Session
Speaker: Hira Mian, MD, MSc, FRCPC – McMaster University, Hamilton, Ontario, Canada
###Speaker: Francesca Gay, MD – Division of Hematology 1, Clinical trial unit AOU città della salute e della scienza, University of Torino
General Session
Speaker: Francesca Gay, MD – Division of Hematology 1, Clinical trial unit AOU città della salute e della scienza, University of Torino
###Panelist: Wee Joo Chng, MB ChB, PhD, FRCP (UK), FRCPath (UK), FAMS – National University Cancer Institute, Singapore
Panelist: Sundar Jagannath, MD, FASCO – Mount Sinai Medical Center, New York, NY, USA
Panelist: Hira Mian, MD, MSc, FRCPC – McMaster University, Hamilton, Ontario, Canada
Panelist: Cristina Gasparetto, MD (she/her/hers) – Department of Medicine, Duke University Cancer Institute, Durham, NC
Panelist: Mohamad Mohty, MD, PhD – Sorbonne University, Saint-Antoine Hospital, AP-HP INSERM UMRs 938, Paris, France
General Session
Panelist: Wee Joo Chng, MB ChB, PhD, FRCP (UK), FRCPath (UK), FAMS – National University Cancer Institute, Singapore
### @@@ Sundar Jagannath, MD, FASCO – Mount Sinai Medical Center, New York, NY, USA ### 1395142###Panelist###Chair for Multiple Myeloma and Professor of Medicine###Mount Sinai Medical Center, New York, NY, USA###Panelist: Sundar Jagannath, MD, FASCO – Mount Sinai Medical Center, New York, NY, USA
### @@@ Hira Mian, MD, MSc, FRCPC – McMaster University, Hamilton, Ontario, Canada ### 1719006###Panelist###Assistant Professor###McMaster University, Hamilton, Ontario, Canada###Panelist: Hira Mian, MD, MSc, FRCPC – McMaster University, Hamilton, Ontario, Canada
### @@@ Cristina Gasparetto, MD (she/her/hers) – Department of Medicine, Duke University Cancer Institute, Durham, NC ### 1441876###Panelist###Professor of Medicine###Department of Medicine, Duke University Cancer Institute, Durham, NC###Panelist: Cristina Gasparetto, MD (she/her/hers) – Department of Medicine, Duke University Cancer Institute, Durham, NC
### she/her/hers @@@ Mohamad Mohty, MD, PhD – Sorbonne University, Saint-Antoine Hospital, AP-HP INSERM UMRs 938, Paris, France ### 1395090###Panelist###Professor of Hematology###Sorbonne University, Saint-Antoine Hospital, AP-HP INSERM UMRs 938, Paris, France###Panelist: Mohamad Mohty, MD, PhD – Sorbonne University, Saint-Antoine Hospital, AP-HP INSERM UMRs 938, Paris, France
###Speaker: Suzanne Lentzsch, MD, PhD (she/her/hers) – Columbia University
Speaker: Andrew R. Branagan, MD, PhD – Massachusetts General Hospital
Speaker: Ravi Vij, MD MBA – Washington University in St. Louis
Career Development
Speaker: Suzanne Lentzsch, MD, PhD (she/her/hers) – Columbia University
### she/her/hers @@@ Andrew R. Branagan, MD, PhD – Massachusetts General Hospital ### 1442194###Speaker###Attending Physician###Massachusetts General Hospital###Speaker: Andrew R. Branagan, MD, PhD – Massachusetts General Hospital
### @@@ Ravi Vij, MD MBA – Washington University in St. Louis ### 1395060###Speaker###Professor###Washington University in St. Louis###Speaker: Ravi Vij, MD MBA – Washington University in St. Louis
###